<DOC>
	<DOCNO>NCT00418743</DOCNO>
	<brief_summary>The purpose study determine treatment efficacy tolerability second-line treatment patient small cell lung cancer compare oral combinaison chemotherapy intravenous combination chemotherapy .</brief_summary>
	<brief_title>Second-line Treatment Patients With Small Cell Lung Cancer ( SCLC )</brief_title>
	<detailed_description>Determined treatment efficacy tolerability second-line treatment patient small cell lung cancer compare oral combinaison chemotherapy intravenous combination chemotherapy .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>Smallcell lung cancer . Patients , ( least ) first line chemotherapy base platinum , partial response progress , complete response relapse within three month follow last course firstline therapy . Measurable assessable disease . Life expectancy &gt; 2 month . Patients therapeutic risk level &lt; 5 point ( see section 6 : `` Treatment flowchart '' ) . Age &gt; 18 year ; Performance status ( WHO ) &lt; 2 ; One measurable target lesion non irradiated region ; Prior radiotherapy authorize unless target measurable lesion ; Biological criterion : WBC &gt; 2000/mm3 , PMN &gt; 1500/mm3 , platelet &gt; 100 000/mm3 , creatinemia &lt; 2 x ULN , bilirubinemia &lt; ULN , ALT AST &lt; 2.5 x ULN ( &lt; 5 N liver metastasis ) normal ECG write informed consent . Non smallcell lung cancer . No objective response platinumbased therapy Complete response last three month last course firstline treatment . Symptomatic brain metastasis . Bone metastases , carcinomatous lymphangitis , ascites pleurisy sole assessable disease manifestation . Concurrent participation another clinical trial . Therapeutic risk level 6 point ( see table ) Uncontrolled clot disorder ; Uncontrolled severe infection ; History another malignancy , except cervical carcinoma situ basocellular cancer consider cure ; Psychological , familial , sociological geographic circumstance prevent treatment followup define protocol ; Patients deprive right administrative legal reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>cancer</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>small-cell lung cancer</keyword>
</DOC>